JP2012502052A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502052A5 JP2012502052A5 JP2011526218A JP2011526218A JP2012502052A5 JP 2012502052 A5 JP2012502052 A5 JP 2012502052A5 JP 2011526218 A JP2011526218 A JP 2011526218A JP 2011526218 A JP2011526218 A JP 2011526218A JP 2012502052 A5 JP2012502052 A5 JP 2012502052A5
- Authority
- JP
- Japan
- Prior art keywords
- porphyrazine
- inhibitors
- imaging
- con
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCSC(C1O*)C11SC(C(*C(c(c2c(cc3)OC(C)C)c3OC(C)C)N/C2=N/C(C2=C3S(CC=S)C(C4)(C4O*)C(C(C4SC4)O*)S2)=N/C3=N/c([n]2)c34)=N/C5=N\c2c3c(OC(C)C)ccc4OC(C)C)=C5SC1C(O*)=* Chemical compound CCSC(C1O*)C11SC(C(*C(c(c2c(cc3)OC(C)C)c3OC(C)C)N/C2=N/C(C2=C3S(CC=S)C(C4)(C4O*)C(C(C4SC4)O*)S2)=N/C3=N/c([n]2)c34)=N/C5=N\c2c3c(OC(C)C)ccc4OC(C)C)=C5SC1C(O*)=* 0.000 description 5
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9502608P | 2008-09-08 | 2008-09-08 | |
| US61/095,026 | 2008-09-08 | ||
| PCT/US2009/055991 WO2010028216A2 (en) | 2008-09-08 | 2009-09-04 | Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012502052A JP2012502052A (ja) | 2012-01-26 |
| JP2012502052A5 true JP2012502052A5 (https=) | 2012-12-13 |
| JP5792066B2 JP5792066B2 (ja) | 2015-10-07 |
Family
ID=41429276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526218A Expired - Fee Related JP5792066B2 (ja) | 2008-09-08 | 2009-09-04 | ポルフィラジン並びに光学的及びデュアル光学的／ｍｒコントラスト並びに治療薬 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8540967B2 (https=) |
| EP (2) | EP2599497A3 (https=) |
| JP (1) | JP5792066B2 (https=) |
| WO (1) | WO2010028216A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2764028A1 (en) * | 2009-06-05 | 2010-12-09 | Institut National D'optique | Hybrid-multimodal magneto-optical contrast marker |
| PT2593127T (pt) * | 2010-07-13 | 2018-07-06 | Georgia State Univ Research Foundation | Agente antiangiogénico e método de usar esses agente |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US8633178B2 (en) | 2011-11-23 | 2014-01-21 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| WO2014164167A1 (en) * | 2013-03-12 | 2014-10-09 | Hoffman/Barrett, L.L.C. | Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| EP3145489A1 (en) | 2014-05-22 | 2017-03-29 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US10722527B2 (en) | 2015-04-10 | 2020-07-28 | Capsugel Belgium Nv | Abiraterone acetate lipid formulations |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2764605B1 (fr) * | 1997-06-17 | 2004-03-26 | Univ Hyderabad | Molecules hybrides d'un photosensibilisateur et d'un agent chimiotherapeutique, leur procede de production et leur application collaterale en chimiotherapie et therapie photodynamique |
| US20020155999A1 (en) * | 1998-04-30 | 2002-10-24 | Han In Suk | Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer |
| US20040192665A1 (en) * | 2002-08-02 | 2004-09-30 | Slil Biomedical Corporation | Conjugates of porphyrin compounds with chemotherapeutic agents |
| NZ543565A (en) * | 2003-05-14 | 2008-12-24 | Univ Sherbrooke | Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
-
2009
- 2009-09-04 EP EP13156925.3A patent/EP2599497A3/en not_active Withdrawn
- 2009-09-04 JP JP2011526218A patent/JP5792066B2/ja not_active Expired - Fee Related
- 2009-09-04 US US13/062,031 patent/US8540967B2/en not_active Expired - Fee Related
- 2009-09-04 WO PCT/US2009/055991 patent/WO2010028216A2/en not_active Ceased
- 2009-09-04 EP EP09792260A patent/EP2340041A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012502052A5 (https=) | ||
| CN100398519C (zh) | 四环苯甲酰胺衍生物及其用法 | |
| US7652028B2 (en) | Indenoisoquinolinone analogs and methods of use thereof | |
| CN101668547B (zh) | 选择缺氧组织的弱碱性2-硝基咪唑递送剂及其应用方法 | |
| JP5792066B2 (ja) | ポルフィラジン並びに光学的及びデュアル光学的／ｍｒコントラスト並びに治療薬 | |
| US7432369B2 (en) | Pyridyl-substituted porphyrin compounds and methods of use thereof | |
| EP2033645A1 (en) | Isoquinoline derivatives and methods of use thereof | |
| WO2011042482A1 (en) | Polyphenols for use in the treatment of cancer | |
| US20080214593A1 (en) | Tetracyclic amino and carboxamido compounds and methods of use thereof | |
| US20100004220A1 (en) | Indenoisoquinolinone Analogs and Methods of Use Thereof | |
| JP2005539011A5 (https=) | ||
| US20100261706A1 (en) | Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof | |
| JP2007525526A (ja) | 四環系ラクタム誘導体およびその使用 | |
| WO2012131035A1 (en) | Composition comprising docetaxel | |
| WO2006093677A1 (en) | Tetracyclic sulfonamide compounds and methods of use thereof | |
| JP2020515591A (ja) | ヒストンデアセチラーゼ６阻害剤としてのイソオキサゾールヒドロキサム酸 | |
| US20080234300A1 (en) | Pyrimido[5,4-c] Quinoline-2, 4-Diamine Derivatives and Methods of Use Thereof |